Literature DB >> 31972211

Impact of PTEN/SOCS3 deletion on amelioration of dendritic shrinkage of retinal ganglion cells after optic nerve injury.

Heather K Mak1, Shuk Han Ng2, Tianmin Ren3, Cong Ye4, Christopher Kai-Shun Leung5.   

Abstract

Retinal ganglion cell (RGC) degeneration, leading to irreversible blindness in chronic optic neuropathies, commonly begins with dendritic shrinkage followed by axon degeneration. Although limited axon regeneration in the optic nerve is possible with a genetic deletion of PTEN/SOCS3 after optic nerve injury, the roles of PTEN/SOCS3 on dendritic preservation and regeneration remain unclear. This study investigated the effect of PTEN/SOCS3 genetic deletion on the structural integrity of RGC dendrites and axons in the retina following optic nerve crush. Using time-lapse, in vivo confocal scanning laser ophthalmoscopy to serially image dendritic and axonal arborizations of RGCs over six months after injury, RGC dendrites and axons were only preserved in Thy-1-YFP/PTEN-/- and Thy-1-YFP/PTEN-/-SOCS3-/- mice, and axons in the retina regenerated at a rate of 21.1 μm/day and 15.5 μm/day, respectively. By contrast, dendritic complexity significantly decreased in Thy-1-YFP-SOCS3-/- and control mice at a rate of 7.0 %/day and 7.1 %/day, respectively, and no axon regeneration in the retina was observed. RGC survival probability was higher in Thy-1-YFP/PTEN-/- and Thy-1-YFP/PTEN-/-SOCS3-/- mice compared with Thy-1-YFP-SOCS3-/- and control mice. The differential responses between the transgenic mice demonstrate that although a genetic deletion of PTEN, SOCS3, or PTEN/SOCS3 allows partial axon regeneration in the optic nerve after optic nerve crush, a deletion of PTEN, but not SOCS3, ameliorates RGC dendritic shrinkage. This shows that the signaling pathways involved in promoting axon regeneration do not equally contribute to the preservation of dendrites, which is crucial to the translational application of neuroregenerative therapies for visual restoration.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Dendritic shrinkage; Optic nerve injury; Phosphatase and tensin homolog (PTEN); Retinal ganglion cell; Suppressor of cytokine signaling 3 (SOCS3)

Year:  2020        PMID: 31972211     DOI: 10.1016/j.exer.2020.107938

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  4 in total

1.  Oral Cancer Cells Release Vesicles that Cause Pain.

Authors:  Zinaida A Dubeykovskaya; Nguyen Huu Tu; Paulina D Ramírez Garcia; Brian L Schmidt; Donna G Albertson
Journal:  Adv Biol (Weinh)       Date:  2022-07-08

2.  Chronic Chemogenetic Activation of the Superior Colliculus in Glaucomatous Mice: Local and Retrograde Molecular Signature.

Authors:  Marie Claes; Emiel Geeraerts; Stéphane Plaisance; Stephanie Mentens; Chris Van den Haute; Lies De Groef; Lut Arckens; Lieve Moons
Journal:  Cells       Date:  2022-05-29       Impact factor: 7.666

3.  Potential Biomarkers and Drugs for Nanoparticle-Induced Cytotoxicity in the Retina: Based on Regulation of Inflammatory and Apoptotic Genes.

Authors:  Dongli Xie; Jianchen Hu; Tong Wu; Kangli Cao; Xiaogang Luo
Journal:  Int J Environ Res Public Health       Date:  2022-05-06       Impact factor: 4.614

4.  A Fair Assessment of Evaluation Tools for the Murine Microbead Occlusion Model of Glaucoma.

Authors:  Marie Claes; Joana R F Santos; Luca Masin; Lien Cools; Benjamin M Davis; Lutgarde Arckens; Karl Farrow; Lies De Groef; Lieve Moons
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.